ScholarIQanswers from OpenAlex & ORCID
Dominique P. Germain
ResearcherPublications, citations & collaboration network
Dominique P. Germain is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Dominique P. Germain have?
ScholarIQindexed works
Dominique P. Germain has 385 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Dominique P. Germain have?
ScholarIQcitation count
Dominique P. Germain has 16,911 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Dominique P. Germain?
ScholarIQh-index
Dominique P. Germain has an h-index of 62 in OpenAlex.
What is the i10-index of Dominique P. Germain?
ScholarIQi10-index
Dominique P. Germain has an i10-index of 142 in OpenAlex.
What is the ORCID of Dominique P. Germain?
ScholarIQorcid
The ORCID for Dominique P. Germain is on the source record.
What is the OpenAlex record for Dominique P. Germain?
ScholarIQopenalex
The OpenAlex for Dominique P. Germain is on the source record.
What are the most-cited papers on Dominique P. Germain?
ScholarIQmost cited works
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortíz, Dominique P. Germain, Robert J. Desnick, Juan Politei, Michael Mauer, Alessandro P. Burlina, Christine M. Eng, Robert J. Hopkin, Dawn A. Laney, Aleš Linhart, Stephen Waldek, Eric Wallace, Frank Weidemann, William R. Wilcox
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani, William R. Wilcox, Claudio Feliciani, Suma P. Shankar, Fatih Süheyl Ezgü, Hernan Amartino, Drago Bratkovic, Ulla Feldt‐Rasmussen, Khan Nedd, Usama Sharaf El Din, Charles Marques Lourenço, Maryam Banikazemi, Joel Charrow, Majed Dasouki, David N. Finegold, Pilar Giraldo, Özlem Göker-Alpan, Nicola Longo, C. Ronald Scott, Roser Torrá, Ahmad Tuffaha, Ana Jovanović, Stephen Waldek, Seymour Packman, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Elfrida R. Benjamin, Franklin K. Johnson, David J. Lockhart, Nina Skuban, Jeff Castelli, Jay Barth, Carrolee Barlow, Raphael Schiffmann
Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease
Dominique P. Germain, Stephen Waldek, Maryam Banikazemi, David A. Bushinsky, Joel Charrow, Robert J. Desnick, Philip Lee, Thomas Loew, Anouk C. Vedder, Rekha Abichandani, William R. Wilcox, Nathalie Guffon
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn Hughes, Kathy Nicholls, Suma P. Shankar, Gere Sunder–Plassmann, David M. Koeller, Khan Nedd, Gerard Vockley, Takashi Hamazaki, Robin Lachmann, Toya Ohashi, Iacopo Olivotto, Norio Sakai, Patrick Deegan, David Dimmock, François Eyskens, Dominique P. Germain, Özlem Göker-Alpan, É. Hachulla, Ana Jovanović, Charles Marques Lourenço, Ichiei Narita, Mark Thomas, William R. Wilcox, Daniel G. Bichet, Raphael Schiffmann, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Franklin K. Johnson, Pol Boudes, Elfrida R. Benjamin, David J. Lockhart, Carrolee Barlow, Nina Skuban, Jeffrey P. Castelli, Jay Barth, Ulla Feldt‐Rasmussen
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
Marieke Biegstraaten, Reynir Arngrı́msson, Frédéric Barbey, Lut Boks, Franco Cecchi, Patrick Deegan, Ulla Feldt‐Rasmussen, Tarekegn Geberhiwot, Dominique P. Germain, Christian J. Hendriksz, Derralynn Hughes, Ilkka Kantola, Nesrin Karabul, Christine Lavery, Gabor E. Linthorst, Atul Mehta, Erica van de Mheen, João Paulo Oliveira, Rossella Parini, Uma Ramaswami, Michael Rudnicki, Andreas L. Serra, Claudia Sommer, Gere Sunder–Plassmann, Einar Svarstad, Annelies Sweeb, Wim Terryn, Anna Tylki‐Szymańska, Camilla Tøndel, Bojan Vujkovac, Frank Weidemann, Frits A. Wijburg, Peter Woolfson, Carla E. M. Hollak